申请人:——
公开号:US20040102449A1
公开(公告)日:2004-05-27
The present invention provides novel heterocyclic amides and related derivatives having the general Formula I
1
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, A, B and Z are as defined in the specification, or a nontoxic pharmaceutically acceptable salt, solvate or hydrate thereof which are openers or activators of KCNQ potassium channels. The present invention also provides pharmaceutical compositions comprising said heterocyclic amides and to the method of treatment of disorders sensitive to KCNQ potassium channel opening activity such as migraine or a migraine attack, bipolar disorders, epilepsy, acute and chronic pain and anxiety.
本发明提供了具有一般式I1的新型杂环酰胺和相关衍生物,其中R1、R2、R3、R4、R5、R6、A、B和Z如规范中所定义,或其无毒药学上可接受的盐、溶剂或水合物,它们是KCNQ钾通道的开放剂或激活剂。本发明还提供了包括上述杂环酰胺的药物组合物以及对于对KCNQ钾通道开放活性敏感的疾病的治疗方法,如偏头痛或偏头痛发作、双相障碍、癫痫、急性和慢性疼痛和焦虑。